✓
Open
1 Sep 2021
✓
Close
3 Sep 2021
3
Allotment
—
✓
Listing
Tue, Sep 14, 2021
Price Band
₹603 to ₹610
Issue Size
93,38,288 shares (agg. up to ₹570 Cr)
Lot Size
24 Shares
Listing Date
Tue, Sep 14, 2021
Latest GMP
₹155
Est. Gain
25.41%
✦ AI Insight
GMP Trend
14-09-2021₹155Est. ₹765+25.41%
13-09-2021₹140Est. ₹750+22.95%
11-09-2021₹155Est. ₹765+25.41%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 44.66x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 |
|---|---|---|---|
| Assets | 413.27 | 231.89 | 213.15 |
| Total Income | 341.99 | 242.49 | 238.90 |
| Profit After Tax | 54.00 | 27.47 | 23.30 |
| EBITDA | 80.15 | 41.02 | 42.08 |
| NET Worth | 166.93 | 111.81 | 82.22 |
| Reserves and Surplus | 135.43 | 101.31 | 71.72 |
| Total Borrowing | 136.64 | 59.42 | 53.90 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Windlas Biotech Ltd. | Mainboard | ₹401.54 Cr | ₹460 | null | ₹407.15 | -11.49% | ₹850.25 (+1.16%) |
| Glenmark Life Sciences Ltd. | Mainboard | ₹1,513.60 Cr | ₹720 | null | ₹748.50 | +3.96% | ₹1,164.10 (-0.31%) |
| Gland Pharma Ltd. | Mainboard | ₹6,479.55 Cr | ₹1500 | null | ₹1,819.55 | +21.30% | ₹2,529.40 (+2.81%) |
| Walpar Nutritions Ltd. | SME | ₹6.60 Cr | ₹55 | null | ₹57.00 | +3.64% | ₹34.50 (+0.00%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment/prepayment of certain financial facilities availed by the Company | 140.00 |
| 2 | Funding working capital requirements of the Company; and | 90.00 |
| 3 | General corporate purposes | 45.98 |
About Ami Organics IPO
Incorporated in 2004, Ami Organics Limited is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals. The company has developed over 450 pharma intermediates across 17 key therapeutic areas i.e. anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It supplies its products to more than 150 customers (including international customers) directly in India and in 25 countries overseas i.e. Europe, USA, China, Israel, Japan, Latin America, etc. Laurus Labs, Cadila Healthcare, Cipla Ltd are some of the domestic customers whereas Organike s.r.l.a. Socio Unico, Fermion Oly, Medichem S.A. and Midas Pharma GmbH are some of the international customers. The company has three manufacturing facilities in Gujarat situated at Sachin, Ankleshwar & Jhagadia, with an aggregate installed capacity of 6,060 MTPA. Competitive strengths: One of the leading manufacturers of certain Pharma Intermediates i.e. Dol
Contact Details
Ami Organics Ltd. AddressPlot No.440/4, 5 & 6, Road No.82/AGIDC SachinSurat, Gujarat, 394230+91 261 239 7193cs@amiorganics.comVisit Website